Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05521321 · ClinicalTrials.gov registry record · NA
Feasibility and Acceptability of the Cannabis Awareness and Prevention Toolkit
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 443
- Enrollment target
NCT05521321: Completed NA study, sponsored by Stanford University.
NCT05521321 is a NA study that has completed, run by Stanford University. The registered enrollment target is 443 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05521321, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 443 participants
- Enrollment target
Study Summary
The Stanford Tobacco Prevention Toolkit is a free, online Toolkit that consists of a curriculum, educational resources, and a resource directory to be used by educators, parents, juvenile justice workers, and healthcare providers to increase knowledge and awareness of cannabis and reduce use among youth. The aim of this study is to investigate the extent to which the curriculum changes students' intentions to use and actual use of cannabis.
Interventions
- BEHAVIORAL Stanford Cannabis Awareness and Prevention curriculum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 443 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2025-05-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05521321
The ClinicalTrials.gov registry entry for NCT05521321 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 443 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stanford Cannabis Awareness and Prevention curriculum is the first listed.
NCT05521321 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05521321 about?
NCT05521321 is a clinical study titled "Feasibility and Acceptability of the Cannabis Awareness and Prevention Toolkit". The Stanford Tobacco Prevention Toolkit is a free, online Toolkit that consists of a curriculum, educational resources, and a resource directory to be used by educators, parents, juvenile justice workers, and healthcare providers to increase knowledge and awareness of cannabis and reduce use among y...
What is the current status of trial NCT05521321?
This trial is currently completed. It is a NA study. The enrollment target is 443 participants. The study started on 2022-10-01. Estimated completion is 2025-05-16.
What interventions are being tested in trial NCT05521321?
The interventions under investigation include: Stanford Cannabis Awareness and Prevention curriculum (BEHAVIORAL).
Who is sponsoring clinical trial NCT05521321?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.